Core Viewpoint - Hainan Puli Pharmaceutical Co., Ltd. has announced that its stock and convertible bonds will enter a delisting arrangement period, with the last trading day set for May 21, 2025, following a decision by the Shenzhen Stock Exchange to terminate their listing [1][2][4]. Group 1: Delisting Announcement - The company received a notice from the Shenzhen Stock Exchange on April 18, 2025, regarding the termination of its stock and convertible bonds listing [2]. - The delisting arrangement period began on April 28, 2025, lasting for fifteen trading days, with the final trading day expected to be May 21, 2025 [4][5]. - During the delisting period, the stock will be traded on the risk warning board of the Shenzhen Stock Exchange, with no price fluctuation limits on the first trading day, followed by a 20% limit on subsequent days [3][4]. Group 2: Trading Rules and Restrictions - The stock and convertible bonds will not be subject to price fluctuation limits on the first trading day of the delisting period, but will have a 20% limit thereafter [3][4]. - Investors are advised that after the delisting, they will not be able to execute conversion, redemption, or repurchase operations until the bonds are listed again [2][5]. - The company will not plan or implement any major asset restructuring during the delisting period [5]. Group 3: Investor Communication - The company will issue risk warning announcements regarding the delisting every five trading days during the first ten trading days and daily during the last five trading days of the delisting period [4]. - Investors are encouraged to refer to the official announcements published on the designated information disclosure media for accurate information [6].